SCHEMBL18436612

SCHEMBL18436612

COC(=O)c1ccc(F)cc1C(O)CF

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.42
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
PDK2 Q15119 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
PDK4 Q16654 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
PLA2G2A P14555 2/20 0.39
CES2 O00748 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18435947 0.83 NPC1 (0.47) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL22907273 0.81 SLC6A4 (0.43) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL18375724 0.81 SLC6A4 (0.45) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL13324495 0.78 SLC6A4 (0.43) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL16954821 0.78 SLC6A4 (0.43) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL2918697 0.78 FFAR4 (0.44) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL2708451 0.75 SLC6A4 (0.51) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL30301996 0.75 SLC6A4 (0.51) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL20601709 0.74 SLC6A4 (0.45) FFAR4SLC6A4SLC6A3NPC1CASP3
SCHEMBL8890759 0.73 PLA2G2A (0.43) FFAR4SLC6A4SLC6A3PLA2G2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2822953-B9 MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES PFIZER (US) 2017-06-21 EP disclosed
EP-2822953-B1 MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES PFIZER (US) 2017-02-01 EP disclosed